← Back to All US Stocks

Cypherpunk Technologies Inc.. (CYPH) Stock Fundamental Analysis & AI Rating 2026

CYPH Nasdaq Pharmaceutical Preparations DE CIK: 0001509745
Updated This Month • Analysis: Mar 23, 2026 • SEC Data: 2025-12-31
Combined AI Rating
SELL
90% Confidence
AGREEMENT
STRONG SELL
92% Conf
SELL
87% Conf

📊 CYPH Key Takeaways

Revenue: $1.5M
Net Margin: 321.5%
Free Cash Flow: $-44.0M
Current Ratio: 35.56x
Debt/Equity: 0.00x
EPS: $0.07
AI Rating: STRONG SELL with 92% confidence
Cypherpunk Technologies Inc.. (CYPH) receives a SELL rating with 90% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $1.5M, net profit margin of 321.5%, and return on equity (ROE) of 3.1%, Cypherpunk Technologies Inc.. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete CYPH stock analysis for 2026.

Is Cypherpunk Technologies Inc.. (CYPH) a Good Investment?

Claude

Cypherpunk Technologies exhibits severe operational distress with negative operating income of -$41.1M against minimal revenue of $1.5M, indicating the company is not operationally viable. The reported net income of $4.8M appears to be driven by non-operating gains rather than business fundamentals, masking underlying deterioration. Negative free cash flow of -$44.0M combined with heavy cash burn and minimal revenue growth presents an unsustainable financial position.

ChatGPT

The company’s fundamentals are weak: revenue is negligible relative to its cost base, operating margin is deeply negative, and both operating cash flow and free cash flow are heavily negative. While the balance sheet is unusually strong with high liquidity, no long-term debt, and substantial equity, current profitability appears low quality because positive net income is not supported by core operations.

Why Buy Cypherpunk Technologies Inc.. Stock? CYPH Key Strengths

Claude
  • + Strong balance sheet with $153.5M stockholders' equity and minimal debt ($0M long-term debt)
  • + Exceptional liquidity with 35.56x current ratio providing runway for operations
  • + Positive net income and earnings per share growth (+103.9% YoY EPS)
ChatGPT
  • + Very strong liquidity with a 35.56x current and quick ratio
  • + Minimal balance sheet risk due to no meaningful debt and only $9.68M in liabilities
  • + Large equity base relative to liabilities provides financial flexibility

CYPH Stock Risks: Cypherpunk Technologies Inc.. Investment Risks

Claude
  • ! Severe operational losses with -$41.1M operating income on $1.5M revenue indicating business model failure
  • ! Massive cash burn of -$44.0M annually with only $14.0M cash on hand providing <4 months of runway
  • ! Net income likely driven by non-operating gains rather than business fundamentals, obscuring true operating performance
  • ! Zero revenue growth (+0.0% YoY) despite being in pharmaceutical sector
  • ! Heavy insider trading activity (22 Form 4 filings in 90 days) may indicate lack of confidence
ChatGPT
  • ! Core business is not economically viable at current scale, with operating margin of -2737.8%
  • ! Cash burn is severe, with operating cash flow of -$43.90M and free cash flow of -$44.00M
  • ! Positive net income appears disconnected from operating performance, raising concerns about earnings quality

Key Metrics to Watch

Claude
  • * Operating cash flow trajectory and burn rate sustainability
  • * Revenue growth acceleration from current 0% YoY stagnation
  • * Cash depletion timeline given -$44.0M annual FCF burn against $14.0M cash balance
ChatGPT
  • * Operating cash burn relative to cash balance
  • * Revenue growth and improvement in operating margin

Cypherpunk Technologies Inc.. (CYPH) Financial Metrics & Key Ratios

Revenue
$1.5M
Net Income
$4.8M
EPS (Diluted)
$0.07
Free Cash Flow
$-44.0M
Total Assets
$163.2M
Cash Position
$14.0M

💡 AI Analyst Insight

Strong liquidity with a 35.56x current ratio provides a solid financial cushion.

CYPH Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin -2,737.8%
Net Margin 321.5%
ROE 3.1%
ROA 3.0%
FCF Margin -2,933.5%

CYPH vs Healthcare Sector: How Cypherpunk Technologies Inc.. Compares

How Cypherpunk Technologies Inc.. compares to Healthcare sector averages

Net Margin
CYPH 321.5%
vs
Sector Avg 12.0%
CYPH Sector
ROE
CYPH 3.1%
vs
Sector Avg 15.0%
CYPH Sector
Current Ratio
CYPH 35.6x
vs
Sector Avg 2.0x
CYPH Sector
Debt/Equity
CYPH 0.0x
vs
Sector Avg 0.6x
CYPH Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Cypherpunk Technologies Inc.. Stock Overvalued? CYPH Valuation Analysis 2026

Based on fundamental analysis, Cypherpunk Technologies Inc.. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
3.1%
Sector avg: 15%
Net Profit Margin
321.5%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.00x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Cypherpunk Technologies Inc.. Balance Sheet: CYPH Debt, Cash & Liquidity

Current Ratio
35.56x
Quick Ratio
35.56x
Debt/Equity
0.00x
Debt/Assets
5.9%
Interest Coverage
-760.50x
Long-term Debt
N/A

CYPH Revenue & Earnings Growth: 5-Year Financial Trend

CYPH 5-year financial data: Year 2020: Revenue $1.5M, Net Income N/A, EPS N/A. Year 2021: Revenue $1.5M, Net Income -$27.5M, EPS $-0.63. Year 2022: Revenue $1.5M, Net Income -$40.6M, EPS $-0.47.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Cypherpunk Technologies Inc..'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-1.81 indicates the company is currently unprofitable.

CYPH Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-2,933.5%
Free cash flow / Revenue

CYPH Quarterly Earnings & Performance

Quarterly financial performance data for Cypherpunk Technologies Inc.. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2022 $375.0K -$10.9M $-0.13
Q2 2022 $375.0K -$9.4M $-0.12
Q1 2022 $375.0K -$9.1M $-0.09
Q3 2021 $375.0K -$7.1M N/A
Q2 2021 $375.0K -$6.5M N/A
Q1 2021 $375.0K -$6.3M N/A
Q3 2020 $375.0K -$7.1M $-0.09
Q2 2020 $375.0K -$6.5M $-0.12

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Cypherpunk Technologies Inc.. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$43.9M
Cash generated from operations
Capital Expenditures
$100.0K
Investment in assets
Dividends
None
No dividend program

CYPH SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Cypherpunk Technologies Inc.. (CIK: 0001509745)

📋 Recent SEC Filings

Date Form Document Action
Apr 10, 2026 8-K tm2611526d1_8k.htm View →
Mar 30, 2026 4 xslF345X06/tm2610113-1_4seq1.xml View →
Mar 17, 2026 4 xslF345X05/tm269084-10_4seq1.xml View →
Mar 17, 2026 4 xslF345X05/tm269084-9_4seq1.xml View →
Mar 17, 2026 4 xslF345X05/tm269084-8_4seq1.xml View →

Frequently Asked Questions about CYPH

What is the AI rating for CYPH?

Cypherpunk Technologies Inc.. (CYPH) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (SELL) with 90% combined confidence, based on fundamental analysis of SEC EDGAR filings.

What are CYPH's key strengths?

Claude: Strong balance sheet with $153.5M stockholders' equity and minimal debt ($0M long-term debt). Exceptional liquidity with 35.56x current ratio providing runway for operations. ChatGPT: Very strong liquidity with a 35.56x current and quick ratio. Minimal balance sheet risk due to no meaningful debt and only $9.68M in liabilities.

What are the risks of investing in CYPH?

Claude: Severe operational losses with -$41.1M operating income on $1.5M revenue indicating business model failure. Massive cash burn of -$44.0M annually with only $14.0M cash on hand providing <4 months of runway. ChatGPT: Core business is not economically viable at current scale, with operating margin of -2737.8%. Cash burn is severe, with operating cash flow of -$43.90M and free cash flow of -$44.00M.

What is CYPH's revenue and growth?

Cypherpunk Technologies Inc.. reported revenue of $1.5M.

Does CYPH pay dividends?

Cypherpunk Technologies Inc.. does not currently pay dividends.

Where can I find CYPH SEC filings?

Official SEC filings for Cypherpunk Technologies Inc.. (CIK: 0001509745) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is CYPH's EPS?

Cypherpunk Technologies Inc.. has a diluted EPS of $0.07.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is CYPH a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, Cypherpunk Technologies Inc.. has a SELL rating with 90% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is CYPH stock overvalued or undervalued?

Valuation metrics for CYPH: ROE of 3.1% (sector avg: 15%), net margin of 321.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy CYPH stock in 2026?

Our dual AI analysis gives Cypherpunk Technologies Inc.. a combined SELL rating for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.

What is CYPH's free cash flow?

Cypherpunk Technologies Inc..'s operating cash flow is $-43.9M, with capital expenditures of $100.0K. FCF margin is -2,933.5%.

How does CYPH compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin 321.5% (avg: 12%), ROE 3.1% (avg: 15%), current ratio 35.56 (avg: 2).

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 23, 2026 | Data as of: 2025-12-31 | Powered by Claude AI